Stocks · Health care · Pharmaceutical Preparations

Cingulate Inc.

CING Clue Score34
United States Fiscal year ends December CIK 0001862150 Results filed 13 Aug 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Peter J. Werth
11 Apr 2024
Director
Exercised, kept indirect
694,096
$0.00
$69.41
Peter J. Werth
11 Apr 2024
Director
Exercised, kept indirect
341,912
$0.00
$683.82

What was left out

Form 4 filings counted 152
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 4
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 2
Transactions with no price 4
Shares from compensation/vesting 1,087,251
Sales filed before the plan box existed 1
History held since 9 Dec 2021